CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity - PubMed (original) (raw)
. 2002 Dec 5;420(6915):502-7.
doi: 10.1038/nature01152.
Affiliations
- PMID: 12466842
- DOI: 10.1038/nature01152
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Yasmine Belkaid et al. Nature. 2002.
Abstract
The long-term persistence of pathogens in a host that is also able to maintain strong resistance to reinfection, referred to as concomitant immunity, is a hallmark of certain infectious diseases, including tuberculosis and leishmaniasis. The ability of pathogens to establish latency in immune individuals often has severe consequences for disease reactivation. Here we show that the persistence of Leishmania major in the skin after healing in resistant C57BL/6 mice is controlled by an endogenous population of CD4+CD25+ regulatory T cells. These cells constitute 5-10% of peripheral CD4+ T cells in naive mice and humans, and suppress several potentially pathogenic responses in vivo, particularly T-cell responses directed against self-antigens. During infection by L. major, CD4+CD25+ T cells accumulate in the dermis, where they suppress-by both interleukin-10-dependent and interleukin-10-independent mechanisms-the ability of CD4+CD25- effector T cells to eliminate the parasite from the site. The sterilizing immunity achieved in mice with impaired IL-10 activity is followed by the loss of immunity to reinfection, indicating that the equilibrium established between effector and regulatory T cells in sites of chronic infection might reflect both parasite and host survival strategies.
Similar articles
- Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.
Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Mendez S, et al. J Exp Med. 2004 Jul 19;200(2):201-10. doi: 10.1084/jem.20040298. J Exp Med. 2004. PMID: 15263027 Free PMC article. - Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity.
Reckling S, Divanovic S, Karp CL, Wojciechowski S, Belkaid Y, Hildeman D. Reckling S, et al. Infect Immun. 2008 Mar;76(3):1179-85. doi: 10.1128/IAI.01093-06. Epub 2007 Dec 17. Infect Immun. 2008. PMID: 18086806 Free PMC article. - CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.
Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, Piccirillo CA. Yurchenko E, et al. J Exp Med. 2006 Oct 30;203(11):2451-60. doi: 10.1084/jem.20060956. Epub 2006 Oct 2. J Exp Med. 2006. PMID: 17015634 Free PMC article. - The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection.
Belkaid Y. Belkaid Y. Expert Opin Biol Ther. 2003 Sep;3(6):875-85. doi: 10.1517/14712598.3.6.875. Expert Opin Biol Ther. 2003. PMID: 12943446 Review. - Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.
Okwor I, Uzonna J. Okwor I, et al. Immunol Res. 2008;41(2):123-36. doi: 10.1007/s12026-008-8016-2. Immunol Res. 2008. PMID: 18389179 Review.
Cited by
- Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in _Leishmania tropica-_infected patients.
Hadifar S, Masoudzadeh N, Heydari H, Mashayekhi Goyonlo V, Kerachian M, Daneshpazhooh M, Sadeghnia A, Tootoonchi N, Erfanian Salim R, Rafati S, Harandi AM. Hadifar S, et al. Front Immunol. 2024 Sep 19;15:1436029. doi: 10.3389/fimmu.2024.1436029. eCollection 2024. Front Immunol. 2024. PMID: 39364404 Free PMC article. - Ex Vivo Analysis of the Association of GFP-Expressing L. aethiopica and L. mexicana with Human Peripheral Blood-Derived (PBD) Leukocytes over 24 Hours.
Ranatunga M, Deacon A, Harbige LS, Dyer P, Boateng J, Getti GTM. Ranatunga M, et al. Microorganisms. 2024 Sep 19;12(9):1909. doi: 10.3390/microorganisms12091909. Microorganisms. 2024. PMID: 39338584 Free PMC article. - Th17 Cell and Inflammatory Infiltrate Interactions in Cutaneous Leishmaniasis: Unraveling Immunopathogenic Mechanisms.
Morales-Primo AU, Becker I, Pedraza-Zamora CP, Zamora-Chimal J. Morales-Primo AU, et al. Immune Netw. 2024 Mar 27;24(2):e14. doi: 10.4110/in.2024.24.e14. eCollection 2024 Apr. Immune Netw. 2024. PMID: 38725676 Free PMC article. Review. - CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
Amorim Sacramento L, Farias Amorim C, G Lombana C, Beiting D, Novais F, P Carvalho L, M Carvalho E, Scott P. Amorim Sacramento L, et al. PLoS Pathog. 2024 May 6;20(5):e1012211. doi: 10.1371/journal.ppat.1012211. eCollection 2024 May. PLoS Pathog. 2024. PMID: 38709823 Free PMC article. - Signaling by Type I Interferons in Immune Cells: Disease Consequences.
Zannikou M, Fish EN, Platanias LC. Zannikou M, et al. Cancers (Basel). 2024 Apr 22;16(8):1600. doi: 10.3390/cancers16081600. Cancers (Basel). 2024. PMID: 38672681 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials